• No results found

[PDF] Top 20 Parkinson’s Disease—Apoptosis and Dopamine Oxidation

Has 10000 "Parkinson’s Disease—Apoptosis and Dopamine Oxidation" found on our website. Below are the top 20 most common "Parkinson’s Disease—Apoptosis and Dopamine Oxidation".

Parkinson’s Disease—Apoptosis and Dopamine Oxidation

Parkinson’s Disease—Apoptosis and Dopamine Oxidation

... makes dopamine from tyrosine and is the rate limiting enzyme in the synthesis of dopamine ...[51]. Dopamine binds to a specific site in the N-terminus and exerts feedback inhibition on the enzyme ... See full document

8

Parkinson’s disease psychosis

Parkinson’s disease psychosis

... The differential for psychotic symptoms in context of PD also includes other forms of dementia such as LBD, Alzheimer’s disease, and vascular dementia. In LBD, neurop- sychiatric symptoms typically precede mild ... See full document

11

<p>Atypical antipsychotics for Parkinson’s disease psychosis: a systematic review and meta-analysis</p>

<p>Atypical antipsychotics for Parkinson&rsquo;s disease psychosis: a systematic review and meta-analysis</p>

... Treatment of PDPsy may be dif fi cult due to the modest ef fi cacy of antipsychotics and the risk of worsening motor function. 9 There are several steps involved in the treatment of PDPsy. Reducing or eliminating ... See full document

13

Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease

Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease

... with Parkinson disease (PD) with postoperative emergence of restless legs syndrome (RLS) had higher preoperative and postoperative dopa- mine agonist (DA) doses, and had a lower percentage of DA reduction ... See full document

5

The Parkin’Play study: protocol of a phase II randomized controlled trial to assess the effects of a health game on cognition in Parkinson’s disease

The Parkin’Play study: protocol of a phase II randomized controlled trial to assess the effects of a health game on cognition in Parkinson’s disease

... functional connectivity between selective brain regions also take place during this degeneration process. Visualization of these changes helps to localize the re- sponsible underlying mechanisms and may be used as a tool ... See full document

11

Dopamine transporter changes after unilateral deep brain stimulation in progressive Parkinson&amp;#39;s disease: a case report

Dopamine transporter changes after unilateral deep brain stimulation in progressive Parkinson&#39;s disease: a case report

... reducing dopamine transporter ...striatal dopamine transporter binding during one year of follow-up after unilateral DBS at the subthalamic ...Parkinson’s disease, dopamine transporter, ... See full document

5

Botulinum toxin for drooling in Parkinson s disease

Botulinum toxin for drooling in Parkinson s disease

... At present the exact mechanism responsible for drooling in PD is not fully understood, but it is generally not considered to be due to overproduction of saliva (Srivanitchapoom 2014). In- deed, a number of studies have ... See full document

17

A Review On Neurodegenerative Diseases:
Types, Pathology &amp; Recent Advancement In Neurodegenerative Treatment

A Review On Neurodegenerative Diseases: Types, Pathology & Recent Advancement In Neurodegenerative Treatment

... Alzheimer‘s disease is identified by the abnormal accumulation of amyloid- β plaques and tau protein extracellularly leading to the formation of intra-neuronal NFT (Neurofibrillary tangles) in the regions of the ... See full document

10

Review: management of Parkinson&amp;#39;s disease

Review: management of Parkinson&#39;s disease

... Parkinson’s disease (PD) is a neurodegenerative disorder, initially characterized by a loss of dopaminergic neurons in the substantia nigra that spreads over the course of the disease to almost the whole ... See full document

20

Sleep disorders in Parkinson&amp;rsquo;s disease

Sleep disorders in Parkinson&rsquo;s disease

... the disease process itself, disrupted sleep due to a variety of motor and nonmotor causes, and the use of dopamine agonists and other antiparkinsonian ...that dopamine agonists are more likely to ... See full document

6

Rasagiline in treatment of Parkinson&amp;rsquo;s disease

Rasagiline in treatment of Parkinson&rsquo;s disease

... surrogate disease markers (LeWitt 2006; Biglan and Ravina 2007; Hung and Schwarzschild ...mediated apoptosis is involved in dopamine neuron loss in Parkinson’s disease (Hirsch et al 1999), ... See full document

10

&lt;p&gt;Validation study of the Parkinson&amp;rsquo;s Fatigue Scale in advanced Parkinson&amp;rsquo;s disease&lt;/p&gt;

<p>Validation study of the Parkinson&rsquo;s Fatigue Scale in advanced Parkinson&rsquo;s disease</p>

... and dopamine, fatigue has been linked both to the reduced serotonergic function in the basal ganglia and limbic areas of the brain and to the dopamine de fi ciency characteristic of ... See full document

12

A review of pulmonary function in Parkinson&amp;rsquo;s disease

A review of pulmonary function in Parkinson&rsquo;s disease

... Parkinson’s disease (PD) is a progressive neurodegenerative disorder, secondary to dopaminergic depletion, which primarily affects motor control via the basal ...multi-system disease affecting dopaminergic ... See full document

11

Spotlight on olfactory dysfunction in Parkinson&amp;#39;s disease

Spotlight on olfactory dysfunction in Parkinson&#39;s disease

... of disease progression, such as dopaminergic neuroimaging, yields a positive predictive value of 97% for differentiating PD from other parkinson- ... See full document

9

Activities of daily living questionnaire from patients’ perspectives in Parkinson’s disease: a cross-sectional study

Activities of daily living questionnaire from patients’ perspectives in Parkinson’s disease: a cross-sectional study

... ’ s disease (PD) is a chronic disorder due to the progressive degeneration of dopamine-producing cells in brain structures, including the substantia nigra ... See full document

7

&lt;p&gt;Evaluation of &amp;alpha;-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson&amp;rsquo;s disease and schizophrenia&lt;/p&gt;

<p>Evaluation of &alpha;-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson&rsquo;s disease and schizophrenia</p>

... objective: Dopamine plays an important role in the disease pathology of Parkinsons disease and ...represent disease end points of the dopaminergic spectrum where ... See full document

13

&lt;p&gt;Cerebrospinal Fluid Proteomics For Identification Of &amp;alpha;2-Macroglobulin As A Potential Biomarker To Monitor Pharmacological Therapeutic Efficacy In Dopamine Dictated Disease States Of Parkinson&amp;rsquo;s Disease And Schizophrenia&lt;/p&gt;

<p>Cerebrospinal Fluid Proteomics For Identification Of &alpha;2-Macroglobulin As A Potential Biomarker To Monitor Pharmacological Therapeutic Efficacy In Dopamine Dictated Disease States Of Parkinson&rsquo;s Disease And Schizophrenia</p>

... Data analysis was done using statistical software SPSS (IBM, version 23.0 Armonk, NY: IBM Corp.). For continuous vari- ables, descriptive statistics such as mean, standard deviation (SD), median and inter-quartile range ... See full document

15

Prevalence of hypersexual behavior in Parkinson&amp;rsquo;s disease patients: Not restricted to males and dopamine agonist use

Prevalence of hypersexual behavior in Parkinson&rsquo;s disease patients: Not restricted to males and dopamine agonist use

... Continuous demographic variables (eg, age of onset, PD duration, NPI, BDI) were analyzed using unpaired t tests. Categorical demographic variables (eg, gender, handedness, marital status, times married, side of PD onset, ... See full document

6

Clinical characteristics of impulse control and related disorders in Chinese Parkinson’s disease patients

Clinical characteristics of impulse control and related disorders in Chinese Parkinson’s disease patients

... PD: Parkinsons disease; PG: Pathological gambling; HS: Hypersexuality; CB: Compulsive buying; BE: Binge eating; DA: Dopamine agonists; QUIP: Questionnaire for Impulsive- Compulsive ... See full document

6

Nonergot dopamine-receptor agonists for treating Parkinson&amp;#39;s disease &amp;ndash; a network meta-analysis

Nonergot dopamine-receptor agonists for treating Parkinson&#39;s disease &ndash; a network meta-analysis

... age, disease duration, disease severity) (Supplementary ...Patients’ disease severity according to Hoehn and Yahr staging generally fell at stages I or II, with only a minor proportion of patients ... See full document

10

Show all 10000 documents...